Drug profile · INN
alteplase
ACTIVASE
alteplase (ACTIVASE) is a tissue-type plasminogen activator exogenous protein. Route of administration: single-use. Current US regulatory status: approved.
Drug details — alteplase
- US status
- approved
- Class
- —
- Route
- SINGLE-USE
- Patents
- 0
- Programs
- 6
- Data quality
- 0.84
Quick answer
alteplase (ACTIVASE) is a tissue-type plasminogen activator exogenous protein. Route of administration: single-use. Current US regulatory status: approved.
Key facts
Mechanism of action
Tissue-type plasminogen activator exogenous protein
Primary target: Tissue-type plasminogen activator
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is alteplase?
alteplase (ACTIVASE) is a tissue-type plasminogen activator exogenous protein. Route of administration: single-use. Current US regulatory status: approved.
What is the brand name for alteplase?
ACTIVASE is a marketed brand name for alteplase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alteplase?
alteplase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.